Search research articles
Contact Us
Filters
Showing results (21-30 of 772) with videos related to
Page
of 78
Sort By:
Annals of the New York Academy of Sciences
|
February 3, 1999
A critical view of the methods for characterization of the VIP/PACAP receptor subclasses
P Robberecht, M Waelbroeck
Metabolic Syndrome and Related Disorders
|
January 26, 2016
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Harry Robberecht, Nina Hermans
The Lancet. Neurology
|
February 26, 2011
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Thomas Philips, Wim Robberecht
Acta Gastro-Enterologica Belgica
|
March 1, 1981
[Carcinoid tumours and carcinoid syndrome. Clinical and biochemical aspects (author's transl)]
A Delcourt, P Robberecht
Nature Reviews. Neurology
|
October 15, 2014
The phenotypic variability of amyotrophic lateral sclerosis
Bart Swinnen, Wim Robberecht
Archives Internationales De Physiologie Et De Biochimie
|
February 1, 1970
[Secretion of hydrolases by perfused fragments of rat pancreas]
P Robberecht, J Christophe
World Journal of Surgery
|
August 31, 1979
Biochemical basis of action of gastrointestinal hormones. Invited commentary
P Robberecht, J Christophe
Endocrinology
|
April 1, 1988
Stimulation and inhibition of pituitary growth hormone release by angiotensin II in vitro
W Robberecht, C Denef
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 1, 1996
Current knowledge on fatty acids in cystic fibrosis
A Christophe, E Robberecht
Cell Biology International Reports
|
November 1, 1990
Evidence for a pertussis toxin-sensitive signalling pathway in the dual action of angiotensin II on growth hormone release in pituitary cell aggregates
W Robberecht, C Denef
Page
of 78
Search research articles
Search
Showing results (21-30 of 772) with videos related to
Sort By:
Page
of 78
Annals of the New York Academy of Sciences
|
February 3, 1999
A critical view of the methods for characterization of the VIP/PACAP receptor subclasses
P Robberecht, M Waelbroeck
Metabolic Syndrome and Related Disorders
|
January 26, 2016
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Harry Robberecht, Nina Hermans
The Lancet. Neurology
|
February 26, 2011
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Thomas Philips, Wim Robberecht
Acta Gastro-Enterologica Belgica
|
March 1, 1981
[Carcinoid tumours and carcinoid syndrome. Clinical and biochemical aspects (author's transl)]
A Delcourt, P Robberecht
Nature Reviews. Neurology
|
October 15, 2014
The phenotypic variability of amyotrophic lateral sclerosis
Bart Swinnen, Wim Robberecht
Archives Internationales De Physiologie Et De Biochimie
|
February 1, 1970
[Secretion of hydrolases by perfused fragments of rat pancreas]
P Robberecht, J Christophe
World Journal of Surgery
|
August 31, 1979
Biochemical basis of action of gastrointestinal hormones. Invited commentary
P Robberecht, J Christophe
Endocrinology
|
April 1, 1988
Stimulation and inhibition of pituitary growth hormone release by angiotensin II in vitro
W Robberecht, C Denef
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 1, 1996
Current knowledge on fatty acids in cystic fibrosis
A Christophe, E Robberecht
Cell Biology International Reports
|
November 1, 1990
Evidence for a pertussis toxin-sensitive signalling pathway in the dual action of angiotensin II on growth hormone release in pituitary cell aggregates
W Robberecht, C Denef
Page
of 78